# Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus

> **NCT01325636** · PHASE1,PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 16 (actual)

## Conditions studied

- Cytomegalovirus Infections
- Adenovirus Infections

## Interventions

- **OTHER:** Cell therapy

## Key facts

- **NCT ID:** NCT01325636
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2014-01
- **Final completion:** 2014-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01325636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01325636, "Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01325636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*